28 - 29 November 2017 | London, UK

Meet the Speakers

Speakers


Dr  Sven  Bostyn
Dr Sven Bostyn
Chair of the Expert Group on patent law in the field of biotechnology and genetic engineering
European Commission
Frank Landolt
Frank Landolt
Vice President, Intellectual Property and Legal
Ablynx
Dieter  Tzschoppe
Dieter Tzschoppe
Director Operations Biotechnology / Pure and Applied organic Chemistry
European Patent Office
Dr.  Roya Ghafele
Dr. Roya Ghafele
Director & Fellow
Oxfirst Ltd. and University Of Oxford
Harriet Strimpel
Harriet Strimpel
Chief IP Officer
New England Biolabs
Claudio Ravizza
Claudio Ravizza
Deputy IP Director, Imaging and Pharma
Bracco
Ms Lise  Ryberg
Ms Lise Ryberg
Global Head of Patents
Novozymes A/S
Mr  Gavin  Lawson
Mr Gavin Lawson
Director, Intellectual Property
Gilead Sciences
Jamie Kemler
Jamie Kemler
Vice President of Intellectual Property and Business Strategy
Stryker
Peter  Dolan
Peter Dolan
Senior Director Global IP
Merial
Ulrika  Agren
Ulrika Agren
Global Intellectual Property Director
Mölnlycke Health Care
Dr Matthias Zigann
Dr Matthias Zigann
Presiding Judge
Munich Regional Court I, Germany
Kevin Mooney
Kevin Mooney
Chairman
Drafting Committee for the Rules of Procedure for the Unified Patent Court
Ian Giles
Ian Giles
Partner
Norton Rose Fulbright
Esteve
Nicolas Ruiz
Director of IP
Esteve